Metraipolis › archive › dc_706bf3e0d76e

Ravulizumab exposure in early pregnancy — Europe PMC PMID:41081867

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41081867
DOI
10.1007/s00277-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-09T09:25:06.496Z
SHA-256 of the archived text
f0af65f5718b4f75ef74ba23c857ebebd916e13a1aaf2b8dfce4d0b22ba9c95c
Stable URL of this page
https://metraipolis.com/documento/dc_706bf3e0d76e

How to cite

Ravulizumab exposure in early pregnancy — Europe PMC PMID:41081867 — Europe PMC (en), https://europepmc.org/article/MED/41081867 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_706bf3e0d76e (Metraipolis archive dc_706bf3e0d76e, sha256 f0af65f5718b4f75ef74ba23c857ebebd916e13a1aaf2b8dfce4d0b22ba9c95c)
BibTeX
@misc{dc706bf3e0d76e,
  title = {Ravulizumab exposure in early pregnancy — Europe PMC PMID:41081867},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41081867},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_706bf3e0d76e; sha256 f0af65f5718b4f75ef74ba23c857ebebd916e13a1aaf2b8dfce4d0b22ba9c95c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41081867. Agents can read the archived copy with the MCP tool read_document.